Market Research Logo

Bristol-Myers Squibb Company - Product Pipeline Review - 2016

Bristol-Myers Squibb Company - Product Pipeline Review - 2016

Summary



Global Markets Direct’s, ‘Bristol-Myers Squibb Company - Product Pipeline Review - 2016’, provides an overview of the Bristol-Myers Squibb Company’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Bristol-Myers Squibb Company, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Bristol-Myers Squibb Company
  • The report provides overview of Bristol-Myers Squibb Company including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Bristol-Myers Squibb Company’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Bristol-Myers Squibb Company’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Bristol-Myers Squibb Company’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Bristol-Myers Squibb Company
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Bristol-Myers Squibb Company’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Bristol-Myers Squibb Company Snapshot
Bristol-Myers Squibb Company Overview
Key Information
Key Facts
Bristol-Myers Squibb Company - Research and Development Overview
Key Therapeutic Areas
Bristol-Myers Squibb Company - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Pipeline Products - Out-Licensed Products
Bristol-Myers Squibb Company - Pipeline Products Glance
Bristol-Myers Squibb Company - Late Stage Pipeline Products
Bristol-Myers Squibb Company - Clinical Stage Pipeline Products
Bristol-Myers Squibb Company - Early Stage Pipeline Products
Bristol-Myers Squibb Company - Drug Profiles
nivolumab
daclatasvir dihydrochloride + asunaprevir
abatacept
apixaban
beclabuvir hydrochloride
brivanib alaninate
ipilimumab
ulocuplumab
BMS-394136
BMS-754807
BMS-833923
BMS-919373
BMS-986020
BMS-986036
BMS-986142
CXL-1427
dasatinib
lirilumab
lulizumab pegol
Recombinant Protein to Antagonize Fibroblast Growth Factor Receptor for Fibrosis
urelumab
BMS-986004
BMS-986012
BMS-986016
BMS-986089
BMS-986148
BMS-986156
BMS-986158
TD-139
Antibody to Target CD40 Ligand for Immunology
Biologic to Inhibit PD-L1 for Immunology
BMS-262084
BMS-777607
BMS-813160
BMS-906024
BMS-963272
BMS-986090
BMS-986104
BMS-986115
BMS-986120
BMS-986141
BMS-986147
BMS-986165
BMS-986168
BMS-986171
BMS-986186
FLX-925
KOS-1803
Recombinant Protein 1 to Antagonize Fibroblast Growth Factor Receptor for Fibrosis
Small Molecule for Oncology
Small Molecule to Antagonize PAR4 for Thromboembolic Disorders
Small Molecule to Inhibit BTK for Immunology
Small Molecule to Inhibit MGAT2 for Type 2 Diabetes and Obesity
Small Molecule to Inhibit TYK2 for Immunology
BMS-817378
ALB-109780
AMR-2
ARX-720
BMS-457
BMS-593214
BMS-654457
BMS-751324
BMS-795311
BMS-816106
BMS-869780
BMS-871
BMS-884775
BMS-986177
BMS-986195
BMS-986205
CXL-1036
Drug for Metabolic Disorders
Drugs to Agonize FPR-2 for Inflammation
DT-1154
F-001287
NP-11948
Small Molecule 2 to Inhibit Factor XIa for Thrombosis
Small Molecule for Pulmonary Arterial Hypertension
Small Molecule to Activate Kv7.2 for Neuropathic Pain and Diabetic Neuropathy
Small Molecule to Antagonize Neuropeptide Y Receptor Y1 for Obesity
Small Molecule to Antagonize NK1R and Block SERT for Depression
Small Molecule to Inhibit IAP for Melanoma
Small Molecule to Inhibit NS5B for Hepatitis C
Small Molecule to Inhibit XIAP and c-IAP for Melanoma
Small Molecules to Inhibit Beta Secretase 1 for Alzheimer's Disease
Small Molecules to Inhibit ROR-Gamma for Inflammation
Monoclonal Antibody Conjugates for Oncology
Proteins for Immunology and Oncology
Small Molecules to Agonize Dopamine D1 Receptor for Cognitive Impairment Associated with Schizophrenia
Small Molecules to Antagonize Calcitonin Gene-Related Peptide for Migraine
Small Molecules to Antagonize CCR2
Small Molecules to Inhibit IDO and TDO for Oncology
Small Molecules to Inhibit IDO for Oncology
Small Molecules to Inhibit JAK 3 for Inflammation and Autoimmune Diseases
Small Molecules to Inhibit JAK2 for Myeloproliferative Disorders
Small Molecules to Inhibit TDO for Oncology
Bristol-Myers Squibb Company - Pipeline Analysis
Bristol-Myers Squibb Company - Pipeline Products by Target
Bristol-Myers Squibb Company - Pipeline Products by Route of Administration
Bristol-Myers Squibb Company - Pipeline Products by Molecule Type
Bristol-Myers Squibb Company - Pipeline Products by Mechanism of Action
Bristol-Myers Squibb Company - Recent Pipeline Updates
Bristol-Myers Squibb Company - Dormant Projects
Bristol-Myers Squibb Company - Dormant Projects
Bristol-Myers Squibb Company - Discontinued Pipeline Products
Bristol-Myers Squibb Company - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Bristol-Myers Squibb Company - Company Statement
Bristol-Myers Squibb Company - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Bristol-Myers Squibb Company - Key Manufacturing Facilities
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Bristol-Myers Squibb Company, Key Information
Bristol-Myers Squibb Company, Key Facts
Bristol-Myers Squibb Company - Pipeline by Indication, 2016
Bristol-Myers Squibb Company - Pipeline by Stage of Development, 2016
Bristol-Myers Squibb Company - Monotherapy Products in Pipeline, 2016
Bristol-Myers Squibb Company - Combination Treatment Modalities in Pipeline, 2016
Bristol-Myers Squibb Company - Partnered Products in Pipeline, 2016
Bristol-Myers Squibb Company - Partnered Products/ Combination Treatment Modalities, 2016
Bristol-Myers Squibb Company - Out-Licensed Products in Pipeline, 2016
Bristol-Myers Squibb Company - Out-Licensed Products/ Combination Treatment Modalities, 2016
Bristol-Myers Squibb Company - Pre-Registration, 2016
Bristol-Myers Squibb Company - Filing rejected/Withdrawn, 2016
Bristol-Myers Squibb Company - Phase III, 2016
Bristol-Myers Squibb Company - Phase II, 2016
Bristol-Myers Squibb Company - Phase I, 2016
Bristol-Myers Squibb Company - IND/CTA Filed, 2016
Bristol-Myers Squibb Company - Preclinical, 2016
Bristol-Myers Squibb Company - Discovery, 2016
Bristol-Myers Squibb Company - Pipeline by Target, 2016
Bristol-Myers Squibb Company - Pipeline by Route of Administration, 2016
Bristol-Myers Squibb Company - Pipeline by Molecule Type, 2016
Bristol-Myers Squibb Company - Pipeline Products by Mechanism of Action, 2016
Bristol-Myers Squibb Company - Recent Pipeline Updates, 2016
Bristol-Myers Squibb Company - Dormant Developmental Projects,2016
Bristol-Myers Squibb Company - Discontinued Pipeline Products, 2016
Bristol-Myers Squibb Company, Other Locations
Bristol-Myers Squibb Company, Subsidiaries
Bristol-Myers Squibb Company, Key Manufacturing Facilities
List of Figures
Bristol-Myers Squibb Company - Pipeline by Top 10 Indication, 2016
Bristol-Myers Squibb Company - Pipeline by Stage of Development, 2016
Bristol-Myers Squibb Company - Monotherapy Products in Pipeline, 2016
Bristol-Myers Squibb Company - Combination Treatment Modalities in Pipeline, 2016
Bristol-Myers Squibb Company - Partnered Products in Pipeline, 2016
Bristol-Myers Squibb Company - Out-Licensed Products in Pipeline, 2016
Bristol-Myers Squibb Company - Pipeline by Top 10 Target, 2016
Bristol-Myers Squibb Company - Pipeline by Route of Administration, 2016
Bristol-Myers Squibb Company - Pipeline by Molecule Type, 2016
Bristol-Myers Squibb Company - Pipeline Products by Top 10 Mechanism of Action,

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report